Apteka Verbascum Spółka z Ograniczoną Odpowiedzialnością (KRS 0000274159, NIP 8581778738) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. Apteka Verbascum operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since February 14, 2007. Apteka Verbascum's most recently reported net revenue was 23.8 M PLN for 2025.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Apteka Verbascum
Identity
- Name
- Apteka Verbascum Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- February 14, 2007
- Registry status as of
- May 10, 2026
- Latest entry
- May 10, 2026
- Founding act
- AKT NOTARIALNY Z DNIA 1 LUTEGO 2007 R. NOTARIUSZ DOROTA ANDRZEJEWSKA, KANCELARIA NOTARIALNA W SZCZECINIE, UL. JAGIELLOŃS…
Articles of association history (3)
- AKT NOTARIALNY Z DNIA 1 LUTEGO 2007 R. NOTARIUSZ DOROTA ANDRZEJEWSKA, KANCELARIA NOTARIALNA W SZCZECINIE, UL. JAGIELLOŃSKA 10/14, REP. A 1374/2007.
- 1 LUTEGO 2010 R., REP. A NR 1495/2010, NOTARIUSZ MAŁGORZATA Z. KRÓL, KANCELARIA NOTARIALNA W ŁODZI - ZMIENIONO §6, §14, §17
- 19 LIPCA 2024 R., REP. A NR 3044/2024, NOTARIUSZ BARTŁOMIEJ JANICKI, KANCELARIA NOTARIALNA W ALEKSANDROWIE ŁÓDZKIM, UCHYLENIE DOTYCHCZASOWEGO TEKSTU UMOWY SPÓŁKI I PRZYJĘCIE NOWEGO BRZMIENIA
Activities
Other activities
Address and contact
- Address
- UL. KINGA C. GILLETTE, 11, 94-406, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-24895-23228-HFJUG-24
Risk and payment profile - Apteka Verbascum
Credibility rating
53 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/19 yrs
Board changes
5
5/19 yrs
PKD changes
2
2/19 yrs
Name changes
0
0/19 yrs
Data from 19 years of registry activity.
Credibility history
Payment reliability score from 2018–2025
Current: D (53/100)
Trend: improving (+2.2 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2018–2025
Current: 574.2 K PLN
Safe: 172.3 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Apteka Verbascum
Founded
February 14, 2007
19 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
52.0 K PLN
104 shares total
Shareholders
2
shareholders
Board
3 people
Filed years
8 years
2018–2025
Registry entries
43
latest: May 10, 2026
Revenue
23.8 M PLN
2025
Net profit
113.8 K PLN
2025
Assets
5.8 M PLN
2025
Equity
1.1 M PLN
2025
EBITDA
318.8 K PLN
2025
Valuation
1.6 M PLN
High confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Apteka Verbascum.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1m capex (+212%), a PLN 1.10 dividend three years running, Cydr Lubelski and Romanian Zarea as the premium engines
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8m of revenue and PLN 49.0m of net profit, while raising capex by 212% to PLN 48.1m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9m acquisition of a Romanian company. Despite the heavy investment cycle the board is keeping the PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7bn (+13% YoY), EBITDA of PLN 56m (+63%) and net profit of PLN 9.3m - a return to the black after a PLN 10m loss in 2024. Poland grew 31%, but CEE was under FX pressure (hryvnia -11% versus the zloty), and a weak Q4 (EBITDA -71% YoY) prompted the supervisory board to cut the 2026 EBITDA target from PLN 100m to PLN 90m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
